A new app called QUiPP could help doctors to better identify women at risk of giving birth prematurely. The app, developed at King's College London, was tested in two studies of high-risk women being monitored at ante-natal clinics.

Researchers at the RIKEN Brain Science Institute in Japan have discovered how to reverse the abnormal axonal development characteristic of CFEOM3, a congenital disease that affects the muscles that control eye movements. Published in Nature Communications, the work shows how creating a specific mutation rescued abnormal axonal growth in the developing mouse brain.

The carcass of a frozen mammoth with signs of weapon-inflicted injuries suggests humans were present in the Eurasian Arctic ten millennia earlier than previously thought. These results, which provide perhaps the oldest known story of human survival in the Arctic region, date human presence there to roughly 45,000 years ago, instead of 35,000 years ago, as previously thought. Paleolithic records of humans in the Eurasian Arctic are scarce. In 2012, a team led by Alexei Tikhonov excavated a partial carcass of a male woolly mammoth from frozen sediments in a coastal bluff on the eastern shore of Yenisei Bay, in the central Siberian Arctic. Through radiocarbon dating of the animal's tibia bone and surrounding materials, the researchers dated it at 45,000 years old.

The Centers for Disease Control recently released survey results from kids showing that many of them had seen some form of advertisement for e-cigarettes. Then they matched them to the uptick in e-cigarette use among young people and implied causation.

There is good news in the annual data report from the United States Renal Data System, coordinating center based at the University of Michigan Kidney Epidemiology and Cost Center, in partnership with Arbor Research Collaborative for Health. 

PROVIDENCE, R.I. [Brown University] -- Combining the drug topiramate with psychological counseling curbed marijuana use among young smokers significantly more than did counseling alone, according to newly published results of a small randomized, controlled trial at Brown University. The results come with a caveat, however: many study volunteers couldn't tolerate the medicine's side effects.

There is no FDA-approved medication for treating cannabis dependence and misuse. Meanwhile, the benefits of counseling treatment, such as motivational enhancement therapy (MET), aren't enough to help many patients, said Robert Miranda Jr., associate professor (research) of psychiatry and human behavior in the Alpert Medical School.